TrialJournal of neurology2024

The impact of metformin use on the outcomes of relapse-remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open-label randomized controlled trial.

Mohamed Y Abdelgaied et al.PubMed ↗Publisher ↗

No numbers read from the abstract.